logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10525106 B1

PDFFull Text
Expired
Date of Patent:
Jan. 07, 2020

Filed:

Feb. 21, 2019

Angiopoietin-based interventions for treating cerebral malaria

Applicants:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

University Health Network, Toronto, CA;

Inventors:

Lisa Arleen Purcell, Garnerville, NY (US);

Sarah J. Higgins, Toronto, CA;

Kevin C. Kain, Toronto, CA;

Assignees:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

University Health Network, Toronto, CA;

Attorneys:

Schwabe, Williamson & Wyatt PC

Gabe Amodeo

Primary Examiner:

Jennifer E Graser

Int. Cl.
CPC ...
A61K 31/365 (2006.01); A61K 38/18 (2006.01); A61K 38/16 (2006.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); C07K 16/22 (2006.01); A61K 45/06 (2006.01); A61K 31/357 (2006.01); A61K 31/49 (2006.01); C07K 14/515 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1891 (2013.01); A61K 31/357 (2013.01); A61K 31/365 (2013.01); A61K 31/49 (2013.01); A61K 38/16 (2013.01); A61K 38/17 (2013.01); A61K 38/18 (2013.01); A61K 38/1866 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C07K 14/515 (2013.01); C07K 16/22 (2013.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); C07K 2319/30 (2013.01); Y02A 50/386 (2018.01); Y02A 50/412 (2018.01);
Abstract

The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin molecule such as AngF1-Fc-F1.

Find Patent Forward Citations

Purcell, Lisa. (2020). Angiopoietin-based interventions for treating cerebral malaria (U.S. Patent No. 10525106). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10525106

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…